OverviewChartNewsTraderScreen

BVT Knock-Out BIIB/  DE000VD47RL7  /

EUWAX
2024-05-24  9:36:32 PM Chg.-0.07 Bid9:59:39 PM Ask9:59:39 PM Underlying Strike price Expiration date Option type
1.34EUR -4.96% -
Bid Size: -		 -
Ask Size: -		 Biogen Inc 205.80 USD 2078-12-31 Call
GlobeNewswire 05-25 BIIB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with ...
GlobeNewswire 05-25 BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire 05-25 Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against...
GlobeNewswire 05-24 BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
GlobeNewswire 05-24 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 05-23 SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Con...
GlobeNewswire 05-23 Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biogen, Inc. (BIIB...
GlobeNewswire 05-23 BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire 05-22 Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Im...
GlobeNewswire 05-21 Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
GlobeNewswire 05-16 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 05-16 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire 05-15 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 05-08 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 05-07 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 05-02 Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 04-29 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 04-25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 04-24 US closes mixed with earnings in limelight
TeleTrader 04-24 Biogen posts Q1 revenue of $2.3 billion
TeleTrader 04-24 US mostly up premarket with earnings in focus
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...